Equity research / Illustrative / 5 min read
Short selling: when the growth story outruns the cash.
A fictional operator puts the gap between reported growth and financial resilience under the microscope.
For / Investment committees & risk teams
Written / 23 Oct 2026
Fictional case study. All named companies and countries in this article are invented. No real security, issuer or jurisdiction is being assessed. Not investment or legal advice.
The case: Project Verdant
Project Verdant is an invented listed cannabis operator, not a real stock. In this illustrative scenario, its investment story rests on new cultivation capacity and an expanding retail footprint. The question is not whether demand can grow. It is whether that growth can generate cash before the company needs more capital.
Revenue alone cannot settle that question. A research team would compare receivables with sales, inventory with sell-through, and operating cash flow with adjusted earnings. Expansion spending, lease obligations and upcoming debt maturities belong in the same analysis.
Build a thesis that can be disproved
The bearish case is that additional capacity reaches the market before demand absorbs it, weakening prices and increasing working-capital needs. That is a hypothesis, not an allegation of misconduct. It should be tested against audited statements, reliable channel evidence and the company’s own disclosures.
The strongest countercase deserves equal attention: improving unit costs, durable distribution, refinancing or regulatory reform could materially change the outcome. Set explicit conditions that would invalidate the thesis instead of interpreting every development as confirmation.
Being right is not enough
Short sellers face potentially unlimited losses, rising borrow costs, recalls and sharp squeezes. A weak business can remain expensive longer than a position can remain funded. Position sizing, liquidity, borrow availability and exit discipline are therefore part of the investment case, not a footnote.
A responsible committee distinguishes evidence from inference, identifies catalysts without assuming their timing, and reviews applicable short-selling and disclosure rules. This fictional case illustrates a research framework; it does not recommend a trade.
The decision lens
A persuasive short thesis must explain both why value is overstated and why the market might recognise it.